{"disease":{"id":"medulloblastoma-shh-activated-and-tp53-mutant","name":"medulloblastoma shh activated and tp53 mutant"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT07242963","title":"Relapsed and Progressive Sonic Hedgehog Medulloblastoma With U1 Mutation Registry Study","phase":"","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Mohammad H. Abu Arja","has_results":false},{"nct_id":"NCT03434262","title":"SJDAWN: St. Jude Children's Research Hospital Phase 1 Study Evaluating Molecularly-Driven Doublet Therapies for Children and Young Adults With Recurrent Brain Tumors","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":68,"lead_sponsor_name":"St. Jude Children's Research Hospital","has_results":false}],"total":2},"guidelines":[],"source":"Drug Landscape verified database"}